COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Why older patients are especially vulnerable to heart damage from COVID-19

COVID-19 enters a person’s heart cells by attacking certain proteins—and when more of those proteins are present, the virus has more chances to cause damage.

Thumbnail

‘No one is safe’: Doctor shares her own experience battling COVID-19

Janet M. Shapiro, MD, thought she had recovered from a mild COVID-19 illness and was ready to get back to work. It turned out, however, that the virus wasn’t done with her quite yet.  

Thumbnail

Statin use lowers the risk of severe illness from COVID-19 by 30%

Some researchers have shared concerns about how statin use may impact COVID-19 patients, but a new meta-analysis suggests there is a significant benefit. 

Thumbnail

Big Ten, Pac-12 cancel 2020 season due to concerns over COVID-19, myocarditis

At this rate, will there be a 2020 college football season at all?

Thumbnail

ACC: Healthcare workers ‘need Congress to act now’ and deliver COVID-19 stimulus

American College of Cardiology President Athena Poppas, MD, penned the statement, emphasizing how important it is for Congress to work together and get things done.

FDA approves emergency use of Impella heart pumps to provide unloading therapy for COVID-19 patients

This is the second EUA for Abiomed's Impella heart pumps during the COVID-19 pandemic.  

Thumbnail

The saga continues: 3 White House experts say hydroxychloroquine ineffective as a COVID-19 treatment

In the last six days, multiple White House experts have all emphasized they don’t support the use of hydroxychloroquine as a treatment option for COVID-19. 

Thumbnail

Updated cardiac imaging recommendations for treating COVID-19 patients

Differentiating between actual signs of a COVID-19 infection and standard cardiac complications can be especially difficult.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.